Generic User Fee Hikes Could Disrupt US FDA Drug Pricing Campaign
Executive Summary
New GDUFA program fee is high enough that sponsors may withdraw applications to reduce their fee exposure, agency estimates.
You may also be interested in...
GDUFA III: How Much Of A Fee Increase Can Industry Stomach?
Amid questions about generic industry market dynamics, the user fee renewal could focus on limiting increases in US FDA collections.
FDA Reports Millions In Unpaid GDUFA Fees
The $20m in generic drug user fee receivables was 12% of the estimated total to be collected in 2018.
US FDA Reports Millions In Unpaid GDUFA Program Fees
The $20m in generic drug user fee receivables was 12% of the estimated total to be collected in 2018.